AR and posterior cortical atrophy: A meta-analysis of 5427 metastatic castration–sensitive PCa (mCSPC) indicated that androgen-receptor-axis-targeted (ARAT) drugs such as enzalutamide can increase overall survival [34]; however, our study suggests that, eventually, resistance may come through AR-independent pathways.